Immunogenicity and safety of different dose schedules and antigen doses of an MF59-adjuvanted H7N9 vaccine in healthy adults aged 65 years and older

Overview of attention for article published in Vaccine, January 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

policy: 1 policy source

twitter: 2 X users

Readers on

mendeley: 34 Mendeley

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 748 followers.

RT @EmmesCRO: Congratulations to Heather Hill on the publication of "Immunogenicity and safety of different dose schedules and antigen dose…

Congratulations to Heather Hill on the publication of "Immunogenicity and safety of different dose schedules and antigen doses of an MF59-adjuvanted H7N9 #vaccine in healthy adults aged 65 years and older" in @ElsevierConnect's Vaccine! https://t.co/Ma6…

Congratulations to Heather Hill on the publication of "Immunogenicity and safety of different dose schedules and antigen doses of an MF59-adjuvanted H7N9 vaccine in healthy adults aged 65 years and older" in Vaccine! https://t.co/Ma6Y70qPou #influenza #…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.